Gram Staining - The Basis of Classification

Fig: Gram stain steps comparing Staphylococcus aureus (G+) and E. coli (G-), with bacterial morphology shapes - Medical Microbiology 9e

Cell Wall Structure - The Key Difference

Fig: Gram-positive cell wall (left) vs Gram-negative cell wall (right). W = peptidoglycan wall, PM = plasma membrane, OM = outer membrane, P = periplasmic space - Sherris & Ryan's Medical Microbiology

Gram-Positive Bacteria

• Thick peptidoglycan layer (20-80 nm, up to ~30 layers)
• Single plasma membrane (monoderm)
• Contains teichoic acids (wall teichoic acid + lipoteichoic acid anchored to plasma membrane)
• NO outer membrane, NO periplasmic space (or minimal)

• Sherris & Ryan's Medical Microbiology, p. 813-814

• Teichoic acids can trigger immune responses
• Peptidoglycan fragments released during infection cause cytokine release and systemic inflammation
• Penicillin targets peptidoglycan synthesis - particularly effective

Gram-Negative Bacteria

• Thin peptidoglycan layer (2-7 nm, 1-2 layers)
• Two membranes (diderm): inner cytoplasmic membrane + outer membrane (OM)
• Periplasmic space between the two membranes containing enzymes and transport proteins
• Outer membrane contains lipopolysaccharide (LPS) - also called endotoxin
• Outer membrane attached to peptidoglycan via lipoproteins

• Medical Microbiology 9e, p. 140-141

• LPS/endotoxin drives severe inflammatory responses and septic shock
• The outer membrane acts as a permeability barrier - many antibiotics cannot penetrate it
• Beta-lactamases (resistance enzymes) often accumulate in the periplasmic space
• Treatment requires antibiotics that can penetrate the outer membrane (e.g., carbapenems, fluoroquinolones)

Side-by-Side Comparison

Special Notes

• Mycobacteria (e.g., M. tuberculosis): Technically Gram-positive by cell wall chemistry, but their wall is rich in waxy mycolic acids that resist Gram stain uptake - they are identified by the acid-fast (Ziehl-Neelsen) stain instead.
• Mycoplasma: No cell wall at all - not classifiable by Gram stain; naturally resistant to penicillin.

Shock

Definition

"Shock is a state of systemic tissue hypoperfusion resulting from reduced cardiac output and/or reduced effective circulating blood volume."

• Robbins, Cotran & Kumar Pathologic Basis of Disease

Types of Shock

1. Hypovolemic Shock

• Cause: Reduced blood or plasma volume
• Examples: Hemorrhage (trauma, GI bleed), burns, severe vomiting/diarrhea, fluid loss
• Mechanism: Low circulating volume → reduced venous return → reduced cardiac output (CO) → tissue hypoperfusion
• Hemodynamics: ↓CVP, ↓PCWP, ↓CO, ↑SVR (compensatory vasoconstriction)

2. Cardiogenic Shock

• Cause: The heart fails to pump adequately
• Examples: Myocardial infarction, ventricular rupture, severe arrhythmias, cardiac tamponade, pulmonary embolism
• Mechanism: Pump failure → ↓CO → inadequate oxygen delivery despite normal blood volume
• Hemodynamics: ↑CVP, ↑PCWP, ↓CO, ↑SVR

3. Distributive Shock

• Hemodynamics: ↓CVP, ↓PCWP, ↑CO (early), ↓SVR

4. Obstructive Shock

• Cause: Physical blockage of blood flow in a major circuit
• Examples: Massive pulmonary embolism, cardiac tamponade, tension pneumothorax
• Mechanism: Obstruction prevents adequate cardiac filling or output
• Hemodynamics: ↑CVP, ↓/↑PCWP, ↓CO, ↑SVR

Hemodynamic Summary Table

Stages of Shock

Stage 1 - Compensated (Non-progressive) Shock

• The body activates compensatory mechanisms to maintain vital organ perfusion
• Baroreceptor reflexes, catecholamines, ADH release, RAAS activation, sympathetic stimulation
• Net result: tachycardia, peripheral vasoconstriction, renal fluid conservation
• Blood is shunted away from skin to the heart and brain
• Skin becomes cool and pale (except in septic shock - skin may initially be warm and flushed)
• No overt organ dysfunction yet; lab may show mild ↑creatinine or ↑lactate
• Reversible with treatment

Stage 2 - Decompensated (Progressive) Shock

• Compensatory mechanisms are overwhelmed
• Widespread tissue hypoxia triggers anaerobic glycolysis → lactic acidosis
• Falling tissue pH causes arteriolar dilation → blood pools in microcirculation
• Worsening CO + endothelial injury → risk of DIC
• Vital organs begin to fail (kidney, lung, brain, gut)
• Still reversible if treated aggressively

Stage 3 - Irreversible Shock

• Widespread cell injury → lysosomal enzyme leakage → further tissue destruction
• Myocardial contractility declines (partly from excess NO synthesis)
• Ischemic gut may release bacteria into the circulation (superimposed bacteremic shock)
• Renal failure from ischemia
• Multi-organ failure and death despite all interventions

Pathophysiology of Septic Shock (in detail)

1. Inflammatory mediators: Microbial PAMPs (e.g., LPS from gram-negative bacteria, peptidoglycan from gram-positives) activate Toll-like receptors → release of TNF, IL-1, IL-6, and other cytokines
2. Endothelial activation and injury: Cytokines loosen tight junctions → vascular leakage → edema → impaired O₂ delivery. Upregulation of NO → systemic vasodilation and hypotension
3. Procoagulant state: Cytokines increase tissue factor → triggers clotting cascade → disseminated intravascular coagulation (DIC) in up to 50% of patients
4. Metabolic derangements: Insulin resistance, hyperglycemia, elevated lactate and triglycerides, lactic acidosis
5. Organ dysfunction: Hypotension + edema + microvascular thrombosis → multi-organ failure (kidneys, lungs → ARDS, heart, brain)

• Mortality remains 20-40% despite modern intensive care
• Most frequently triggered by gram-positive bacteria, then gram-negatives, then fungi

Morphological Changes in Shock (Organ Effects)

Clinical Signs of Shock

• Hypotension (systolic BP <90 mmHg or MAP <65 mmHg) - but not always present early
• Tachycardia
• Cool, clammy, pale skin (or warm/flushed in sepsis/distributive)
• Altered mental status (confusion, agitation)
• Oliguria/anuria (urine output <0.5 mL/kg/hr)
• Elevated serum lactate (marker of tissue hypoperfusion)
• Metabolic acidosis

General Principles of Management

1. Recognize shock early - high clinical suspicion in any patient with hypotension or new organ dysfunction
2. Identify the type - history, exam, hemodynamic monitoring
3. Restore oxygen delivery simultaneously with diagnostic workup - do not delay
4. Fluid resuscitation with crystalloids (balanced solutions preferred)
5. Vasopressors (norepinephrine first-line) if fluids alone cannot maintain MAP ≥65 mmHg
6. Treat the underlying cause (antibiotics for sepsis, PCI for cardiogenic, epinephrine for anaphylaxis, surgery for hemorrhage)
7. Involve the multidisciplinary team (ICU, surgery, cardiology as needed)